Aveanna Healthcare (AVAH) reported $670.48 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 13.7%. EPS of $0.22 for the same period compares to $0.18 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $647.08 million, representing a surprise of +3.62%. The company delivered an EPS surprise of +29.41%, with the consensus EPS estimate being $0.17.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Aveanna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Hours - PDS: 12,413.00 hrs versus the two-analyst average estimate of 12,099.02 hrs.
-
Revenue rate - MS: $500.33 versus $488.94 estimated by two analysts on average.
-
Unique patients served (UPS) - MS: 95 versus 95 estimated by two analysts on average.
-
Revenue rate - PDS: $44.62 compared to the $43.81 average estimate based on two analysts.
-
Revenue- PDS: $553.93 million versus $530.01 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +14% change.
-
Revenue- MS: $47.53 million versus $46.23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.5% change.
-
Revenue- HHH: $69.02 million versus $65.79 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +14.8% change.
View all Key Company Metrics for Aveanna here>>>
Shares of Aveanna have returned -5.7% over the past month versus the Zacks S&P 500 composite's +2.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Aveanna Healthcare Holdings Inc. (AVAH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
